1065183-64-3 Usage
General Description
1H-Indole-1-carboxylic acid, 6-fluoro-2,3-dihydro-, 1,1-dimethylethyl ester, is a chemical compound with a complex structure predominantly used in scientific experiments and research. The chemical is classified as an ester – an organic compound produced by the reaction of an acid and an alcohol with the elimination of a molecule of water. Not much information is available on its specific uses or properties. However, like other similar compounds, it may be used in the development or creation of pharmaceutical drugs, or various other chemical or industrial applications. Its hazard and safety characteristics, environmental impact, and specific physical and chemical properties should be identified before working with it.
Check Digit Verification of cas no
The CAS Registry Mumber 1065183-64-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,6,5,1,8 and 3 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1065183-64:
(9*1)+(8*0)+(7*6)+(6*5)+(5*1)+(4*8)+(3*3)+(2*6)+(1*4)=143
143 % 10 = 3
So 1065183-64-3 is a valid CAS Registry Number.
1065183-64-3Relevant articles and documents
4,5,6,7-TETRAHYDRO-1 H-PYRAZOLO[4,3-C]PYRIDIN-3-AMINE COMPOUNDS AS CBP AND/OR EP300 INHIBITORS
-
Page/Page column 310, (2016/06/14)
The present invention relates to compounds of formula (I) or formula (II): and to salts thereof, wherein R1-R4 of formula (I) and R1-R3 of formula (II) have any of the values defined herein, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) of formula (II) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders.
PURINE DERIVATIVES AS KINASE INHIBITORS
-
Page/Page column 79, (2008/06/13)
The present invention provides kinase inhibitors of Formula I.